Immunogenicity of tumor antigens.
D000818:Animals; D000951:Antigens, Neoplasm / Q000008:administration & dosage / Q000302:isolation & purification / Q000528:radiation effects; D000956:Antigens, Viral; D001500:BCG Vaccine / Q000494:pharmacology; D002273:Carcinogens; D004622:Embryo, Mammalian / Q000276:immunology; D000939:Epitopes; D006183:H-2 Antigens; D006801:Humans; D007108:Immune Tolerance; D007109:Immunity; D007694:Killer Cells, Natural / Q000276:immunology; D008214:Lymphocytes / Q000276:immunology; D008264:Macrophages / Q000276:immunology; D051379:Mice; D009374:Neoplasms, Experimental / Q000209:etiology / Q000276:immunology*; D009858:Oncogenic Viruses / Q000276:immunology; D012313:RNA / Q000276:immunology; D012190:Retroviridae / Q000276:immunology; D013045:Species Specificity; D014412:Tumor Virus Infections / Q000276:immunology
D000951:Antigens, Neoplasm; D000956:Antigens, Viral; D001500:BCG Vaccine; D002273:Carcinogens; D000939:Epitopes; D006183:H-2 Antigens; D012313:RNA